NCT05570786View on ClinicalTrials.gov

Subdermal Implant-bioabsorbable Gestrinone Pellet for Endometriosis Pelvic Pain Treatment

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 13, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Deep EndometriosisPelvic Pain
Interventions
DRUG

Gestrinone

The intradermal gestrinone/placebo pellet will be inserted on the same day as the levonorgestrel intrauterine hormonal device (Kyleena®)

DRUG

Placebo

Subdermal implant-bioabsorbable placebo pellet (cholesterol)

Trial Locations (1)

Unknown

Science Valley Research Institute, São Paulo

Sponsors

Collaborators (1)

Biós Farmacêutica
All Listed Sponsors
collaborator

Biós Farmacêutica

UNKNOWN

lead

Science Valley Research Institute

OTHER